MedPath

Synaptic density in psychotic disorders

Conditions
Schizophrenia, schizoaffective disorder, schizophreniform disorder
Registration Number
NL-OMON27759
Lead Sponsor
Prof. Dr. I.E.C. Sommer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
78
Inclusion Criteria

1.The participant understands the study and is able to provide written informed consent
2.Must be between the ages of 26-40
3.For patients: must have a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder
4.For siblings: must have 1 brother or sister with a disorders specified under point 3. The sibling is not necessarily related to one of the participants from the patient group.
5.For controls: participants must be free of any psychiatric or neurological disease and should not have any first- or second-degree relatives with one of the disorders specified under point 3.

Exclusion Criteria

1.Participation in a scientific research study during the past year involving radiation (or exposure to the same amount of ratiation within the past year via other means, e.g., transatlantic flights)
2.MR incompatible implants in the body
3.The possibility of having metal particles in the eyes
4.Tattoo’s containing red pigments that form a safety risk
5.Inability to undergo cognitive testing in Dutch
6.Dangerous or harmful behaviour (i.e. behaviour with a risk of severe physical injury, or actual physical injury inflicted, to self or others) occurred in last 3 months
7.Possibility of pregnancy
8.Intake of levetiracetam or brivaracetam

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameter is the relationship between synaptic density and cognitive functioning and the potentially mediating role of functional connectivity in this relationship.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath